<code id='D13D8634FE'></code><style id='D13D8634FE'></style>
    • <acronym id='D13D8634FE'></acronym>
      <center id='D13D8634FE'><center id='D13D8634FE'><tfoot id='D13D8634FE'></tfoot></center><abbr id='D13D8634FE'><dir id='D13D8634FE'><tfoot id='D13D8634FE'></tfoot><noframes id='D13D8634FE'>

    • <optgroup id='D13D8634FE'><strike id='D13D8634FE'><sup id='D13D8634FE'></sup></strike><code id='D13D8634FE'></code></optgroup>
        1. <b id='D13D8634FE'><label id='D13D8634FE'><select id='D13D8634FE'><dt id='D13D8634FE'><span id='D13D8634FE'></span></dt></select></label></b><u id='D13D8634FE'></u>
          <i id='D13D8634FE'><strike id='D13D8634FE'><tt id='D13D8634FE'><pre id='D13D8634FE'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:173
          A woman uses her phone to scan a barcode. -- Health coverage from STAT
          A Color Health service promises to make it easier to get cancer screenings. Color Health

          Color Health wants to take away any reason you might have for skipping screenings for cancer. 

          The Silicon Valley company, which pivoted from cancer genomics to Covid-19 testing on a large and hugely profitable scale, has a new program that incorporates both its roots in cancer testing and its logistical experience from the pandemic. Called, simply, the Cancer Prevention and Screening Program, and built in partnership with the American Cancer Society, the program aims to make it easy to get the appropriate screenings, whether at a clinic or at home. 

          advertisement

          “If we can take away all your excuses for not doing the prevention, can we get you to do the prevention,” said Alicia Zhou, the company’s chief scientific officer. “It’s bringing the care to the patient, instead of bringing the patient to care.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          FDA approves first blood sugar monitor without finger pricks
          FDA approves first blood sugar monitor without finger pricks

          TheFDAhasapprovedadevicefromAbbottthatcontinuouslymonitorsdiabetics’bloodsugarlevelswithoutrequiring

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

          1:45RandallMargraves,right,talkstoattorneyMickGrewal,ashepreparestostandinfrontofJudgeJaniceCunningh